Summary and conclusions
Out of 1300 patients referred to a medical oncology unit, there were 87 with metastatic cancer in whom a primary tumour site was not evident from the history and after physical examination and chest radiography had been carried out. An analysis of the investigations performed in these patients and their results showed that in only eight of the 87 patients did non-surgical investigations at presentation determine the primary site. In two patients it was identified by diagnostic laparotomy, and in a further 13 clinical follow-up led to recognition of the primary tumour site before death.
Few investigations should be performed in patients in whom the primary site is not known since they have a low yield, and in our population identifying the primary tumour did not improve the outcome or alter management. Treatable tumours should be excluded, and this may be done in most cases by simple blood tests, particularly those measuring acid phosphatase activity and other tumour markers.
Introduction
Patients often present with metastatic malignant disease without an obvious primary tumour. The dilemma facing the clinician is how aggressively to try to identify the primary site. Traditionally, in medical wards large series of non-invasive investigations are undertaken, while in surgical wards a more rapid progression to exploratory laparotomy is common. The argument for pursuing the primary site aggressively in these patients is usually based on two beliefs: that finding the primary site might, firstly, lead to specific antitumour treatment and, secondly, give a better guide to prognosis. A possible further reason may be the diagnostic challenge posed by such patients.
We have reviewed the clinical histories of 1300 patients with malignant disease referred to this newly established medical oncology department in a major teaching hospital. Patients who presented initially with metastatic adenocarcinoma and undifferentiated carcinoma (confirmed histologically or cytologically) in whom the clinical history, full physical examination including breast palpation and pelvic examination, and chest radiography did not identify the primary site were studied.
Eighty-seven patients (6-70/o) fell into this category, and the investigations in these patients and natural history of the disease constitute this report.
Patients and methods
The clinical staff of this institute saw 1300 patients with cancer between January 1977 and October 1978. All clinical histories were reviewed retrospectively, and patients who presented initially with metastatic cancer without a documented primary site on clinical history, examination, and chest radiography were studied further. Only patients with metastatic non-squamous carcinoma based on review of the initial histological specimens were included. All investigations were recorded, including those before referral and those that were not designed specifically to identify the primary tumour site. The unit's policy was to discourage exhaustive investigations to find the primary site, but in patients considered to be suitable for trials of chemotherapy staging investigations to assess the disease were encouraged. The radiological procedures were routine, and nuclear-medicine scans were performed in a single department where the bone-scanning radionucleide used is technetium-labelled pyrophosphate and the liver-scanning agent technetium-99m sulphacolloid. Technetium pertechnetate was used for thyroid and brain scans, and cerebral CAT scans were performed in certain patients. The haematological and biochemical investigations were by standard techniques.
The results of investigations designed to identify the primary sites Table I shows the ages of the patients studied and of the total population seen at this institute during the period of analysis. The patients with unknown primary adenocarcinoma tended to be slightly older than the general population of patients with cancer.
Physical signs at presentation- Table II shows the clinical signs and predominant sites of disease at initial presentation. In eight patients the abnormality was seen only on chest radiography. The initial diagnosis of malignant disease was established by open biopsy in 69 patients, by cytology in 14, and by both methods in four. Table III shows the sites of tissue analysed initially.
Diagnostic investigations-Many investigations were carried out to identify the site of the primary tumour. The primary site was identified before death in 23 patients (26%), in only 10 (11 Oo) by investigations (including laparotomy) conducted at the time of initial presentation.
Blood tests-Serum acid phosphatase activity was measured in only 22 of the 45 male patients and was raised in three. In two patients prostatic cancer was diagnosed by biopsy, but in the third patient no histological evidence of prostatic carcinoma was obtained. Concentrations of 5-human chorionic gonadotrophin (3-HCG) were raised in the two patients subsequently shown to have germ-cell tumours. Serum concentrations of carcinoembryonic antigen (CEA) were measured in 25 of the 87 patients: they were appreciably raised in eight patients and marginally raised in seven. In four of the eight patients with appreciably increased concentrations ( >25 ng/ml) a primary tumour site was diagnosed before death: two had colonic primary tumours, one a lung carcinoma, and one an ovarian adenocarcinoma. A diagnosis was made before death in two of the 17 with normal or marginally raised concentrations: one had ovarian and the other a thyroid carcinoma.
Radiological investigations-Intravenous pyelograms (IVPs) were obtained in 35 patients and in two were thought to be diagnostic of primary renal tumours. These were both false-positive results, since subsequent investigations did not confirm a primary tumour at this site. The IVP showed a false-negative result in one patient, who presented 12 months later with haematuria and at operation was found to have a primary renal carcinoma. Fourteen of the 42 female patients underwent mammography, which in no case was diagnostic of primary breast cancer.
Barium studies-Twenty-four barium-meal examinations were performed, and four were thought to be diagnostic of gastric carcinoma. One patient had a primary gastric tumour, but in the other three the results were false-positive, since subsequent investigations did not confirm primary gastric tumours. One false-negative result was obtained, in a patient who at postmortem examination was found to have a primary gastric tumour. Twenty-seven barium enemas were performed, and in seven cases were thought to be diagnostic of primary colorectal neoplasms. Four of these patients proved to have primary colorectal tumours, but in the remaining three subsequent investigations failed to confirm such tumours.
Radionucleide scans-One of the 16 thyroid scans was thought to be diagnostic of a primary carcinoma, but this was a false-positive result since subsequent investigation did not confirm a thyroid cancer. One false-negative thyroid scan was obtained in a patient who one year later was found to have a primary follicular carcinoma of the thyroid. . =Patients with pulmonary disease (17; five lost to followup). 0 =Patients with liver disease (13; two lost to follow-up).
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lymphadenopathy had a prolonged median survival compared with the other two groups. There was no difference in median survival time between patients in whom the primary tumour site was identified during life and those in whom it was not (fig 3) . The duration of symptoms before histological diagnosis did not affect survival. Age-Patients under the mean age (57 years) had a median survival of 20 weeks compared with nine weeks for those who were older. In two patients death was not directly related to malignant disease, as one died after an open lung biopsy and one of a saddle embolus four weeks after histological diagnosis of intra-abdominal tumour. 
Discussion
Unknown primary metastatic adenocarcinoma was diagnosed in 6-7% of the patients seen at our clinic. This incidence is higher than that reported previously,l 2 but others have restricted this diagnosis to patients in whom extensive investigations aimed at identifying the primary site have yielded negative results. We believe that the term unknown primary adenocarcinoma should include all patients who present with histologically confirmed metastatic adenocarcinoma in whom the history, clinical examination, and chest radiography do not identify the primary site.
The mean age of 57 years in our series is similar to that reported by others. (p-HCG and a-fetoprotein), and imaging of pelvic organs. The possibility that investigations of biopsy specimens might identify sensitive tumours has been raised by reports of unknown primary tumours containing oestrogen receptors responding to hormonal treatment.5 6 We now measure oestrogen-receptor concentrations in tumours other than breast and uterine cancers but did so in only one of the patients in this series, in whom they were absent. The better prognosis of patients with metastatic lymphadenopathy without a primary tumour site has been reported.3 Whether this improved survival reflects less-extensive disease rather than an immunologically mediated phenomenon is not clear. Many of the patients in our series underwent staging investigations. The purpose of these investigations may be questioned, and in general their justification is that they are baseline measurements of tumours before treatment. Analysis of our results indicated that liver scans are rarely positive in patients without severely altered liver function and hepatomegaly.
Others have reported that the commonest primary sites in patients with metastatic malignant disease and no primary tumour after investigation are the lung and pancreas.7 The commonest sites of primary tumours in our patients were the lung, colon, and ovary. This difference presumably reflects the fact that our patient group was defined -as having metastatic malignant disease with no primary tumour site at presentation before investigation. The exception, the local government authorities are disposed to think that the system of rewards for the destruction of snakes has not had, and probably will not have, any material effect upon the mortality. The reasons given for this distrust are interesting. It appears that a large proportion of the snakes killed were caught and brought in by professional snake-catchers from places remote from human habitations, where they would probably never have had the opportunity of killing a single human being. A careful investigation of the numerous cases of death from snake-bites shows that the majority of them occur in or near dwelling-houses. The fact that the number of females who die from snake-bites is larger than the number of males, seems to show that the cases occur in villages and homesteads rather than in the open fields. An observation by Sir Ashley Eden suggests the same conclusion. He points out that, whereas tigers kill twenty times as many cattle as they do persons, snakes kill twenty times as many persons as they do cattle. The Indian Government is of opinion that "the mortality from snake-bites is attributable to the mode of life of the people. It is preventable by them if they are prepared to change this mode of life; but it is preventable in no other way. So long as the people allow their homes to be surrounded by rank vegetation, old bricks, and rubbish, and go out into this natural abode of snakes in the night without a light, and often without any protection for their feet, so long will they be exposed to the risk of snake-bites. The recklessness of the people in regard to the adoption of ordinary precautions against accidents of this kind is so much a part of the national character, that nothing that Government can do is likely materially to effect any substantial good." It is, nevertheless, determined to continue the system of rewards, with precautions against its abuse, for some little time longer; and, at the same time, to impress upon all landed proprietors and farmers the necessity of removing from the dwellings of themselves and their labourers the arrangements for promoting the multiplication of snakes which at present surround them. (British Medical Journal, 1879.)
